Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the treatment of obesity. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://craiglauc437746.imblogs.net/88601009/retaglutide-a-promising-glp-1-receptor-agonist